A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression

Cancer Letters

Volumn 200, Issue 1, 2003, Pages 49-55

  Nishioka, Yoshihiro ^a   Sagae, Satoru ^a   Nishikawa, Akira ^a   Ishioka, Shin Ichi ^a   Kudo, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Matrix metalloproteinase 1; Single nucleotide polymorphism

Indexed keywords

INTERSTITIAL COLLAGENASE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENETIC CORRELATION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0141862296     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00411-7     Document Type: Article

References (26)

1. Walboomers J., Jacobs M.V., Manos M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:1999;12-19.
2. Helland A., Langerod A., Johnsen H., Olsen A.O., Skovlund E., Borresen-Dale A.L. p53 polymorphism and risk of cervical cancer. Nature. 396:1998;530-531.
3. Hayes V.M., Hofstra R.M., Buys C.H., Hollema H., van der Zee A.G. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet. 352:1998;1756.
4. Stanczuk G.A., Sibanda E.N., Perrey C., Chirara M., Pravica V., Hutchinson I.V., Tswana S.A. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int. J. Cancer. 94:2001;792-794.
5. Roh J.W., Kim M.H., Seo S.S., Kim S.H., Kim J.W., Park N.H., Song Y.S., Park S.Y., Kang S.B., Lee H.P. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett. 184:2002;57-63.
6. Stetler-Stevenson W.G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 148:1996;1345-1350.
7. Brummer O., Bohmer G., Hollwitz B., Flemming P., Petry K.U., Kuhnle H. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation - an immunohistochemical study. Gynecol. Oncol. 84:2002;222-227.
8. Moser P.L., Kieback D.G., Hefler L., Tempfer C., Neunteufel W., Gitsch G. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer. Anticancer Res. 19:1999;4391-4393.
9. Rutter J.L., Mitchell T.I., Buttice G., Meyers J., Gusella J.F., Ozelius L.J., Brinckerhoff C.E. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58:1998;5321-5325.
10. Kanamori Y., Matsushima M., Minaguchi T., Kobayashi K., Sagae S., Kudo R., Terakawa N., Nakamura Y. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 59:1999;4225-4227.
11. Nishioka Y., Sagae S., Ishioka S., Nishikawa A., Matsushima M., Kanamori Y., Minaguchi T., Nakamura Y., Tokino T., Kudo R. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn. J. Cancer Res. 91:2000;612-615.
12. Zhu Y., Spitz M.R., Lei L., Mills G.B., Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 61:2001;7825-7829.
13. Ye S., Dhillon S., Turner S.J., Bateman A.C., Theaker J.M., Pickering R.M., Day I., Howell W.M. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 61:2001;1296-1298.
14. Ghilardi G., Biondi M.L., Mangoni J., Leviti S., DeMonti M., Guagnellini E., Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res. 2001:(7):2001;2344.
15. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., Fujinaga K. Simultaneous detection and typing of genital human papilloma virus DNA using the polymerase chain reaction. J. Gen. Virol. 72:1991;1039-1044.
16. Borden P., Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7:1997;159-178.
17. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:1993;197-250.
18. Van Trappen P.O., Ryan A., Carroll M., Lecoeur C., Goff L., Gyselman V.G., Young B.D., Lowe D.G., Pepper M.S., Shepherd J., Jacobs I.J. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br. J. Cancer. 87:2002;537-544.
19. Kato Y., Yamashita T., Ishikawa M. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol. Rep. 9:2002;565-569.
20. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89:1997;1260-1270.
21. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2:1996;461-462.
22. Murray G.I., Duncan M.E., O'Neil P., McKay J.A., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185:1998;256-261.
23. Ito T., Ito M., Shiozawa J., Naito S., Kanematsu T., Sekine I. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod. Pathol. 12:1999;669-674.
24. Inoue T., Yashiro M., Nishimura S., Maeda K., Sawada T., Ogawa Y., Sowa M., Chung K.H. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int. J. Mol. Med. 4:1999;73-77.
25. Cuzick J., Terry G., Ho L., Monaghan J., Lopes A., Clarkson P., Duncan I. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br. J. Cancer. 82:2000;1348-1352.
26. Wyatt C.A., Coon C.I., Gibson J.J., Brinckerhoff C.E. Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res. 62:2002;7200-7202.